0001209191-17-050214.txt : 20170824 0001209191-17-050214.hdr.sgml : 20170824 20170824191958 ACCESSION NUMBER: 0001209191-17-050214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170823 FILED AS OF DATE: 20170824 DATE AS OF CHANGE: 20170824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Field Janet Risi CENTRAL INDEX KEY: 0001713140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14468 FILM NUMBER: 171050244 MAIL ADDRESS: STREET 1: 9200 SOUTH DADELAND BOULEVARD, SUITE 800 CITY: MIAMI STATE: FL ZIP: 33156 FORMER NAME: FORMER CONFORMED NAME: Risi Janet DATE OF NAME CHANGE: 20170726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-23 0 0001006028 PURE BIOSCIENCE, INC. PURE 0001713140 Field Janet Risi 9200 SOUTH DADELAND BOULEVARD, SUITE 800 MIAMI FL 33156 1 0 0 0 Common Stock 2017-08-23 4 A 0 150000 0.00 A 164140 D Stock Option (Right to Buy) 1.21 2017-08-23 4 A 0 200000 0.00 A 2027-08-23 Common Stock 200000 200000 D Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. /s/ Janet Risi Field 2017-08-24